A specific monoclonal antibody (MAb; EG 02 154/12) directed against a protein epitope of Echinococcus granulosus antigen 5 was used to screen a cDNA library constructed from E. granulosus protoscoleces RNA. One clone designated Eg14 was selected and shown to code for an amino acid sequence partially homologous to that of the clone Eg6 previously identified with the same MAb. Hydrophobic cluster analysis showed that both recombinant antigens may adopt a similar a-helical organization and share a common conformational epitope. A synthetic peptide (89-122) mimicking the conformational site of Eg6 and Eg14 was constructed and demonstrated to be able to inhibit binding of the MAb and human hydatid sera to the Eg6 fusion protein (FP6) or to native hydatid antigens. To assess the diagnostic value of the peptide 89-122, we tested sera from patients infected with different parasites for their antibody reactivity with this peptide in ELISA. A high binding sensitivity and specificity of IgG-A-M antibodies were obtained with E. granulosus-infected patient sera. Moreover, the peptide 89-122 was found to be specifically recognized by IgE antibodies from patients with hydatid disease. These results indicate the particular interest ofthis synthetic peptide as a standardized antigen in diagnosis and treatment surveillance of hydatidosis. (J. Clin. Invest. 1992.89:458-464.) Key words: a-helical organization . hydrophobic cluster analysis* immunodiagnosis of hydatidosis * monoclonal antibody * recombinant protein , synthetic peptide
Introduction
Hydatidosis, caused by the larval stage of the tapeworm Echinococcus granulosus, is one of the major public health problems in many areas of the world (1) . Because the symptoms vary according to the location of the parasite and its rate of growth, the clinical diagnosis of hydatidosis in humans is often very difficult. The need therefore exists for immunodiagnostic procedures, both for the detection of cases for early treatment and the evaluation of progress in hydatidosis control program.
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Among hydatid cyst fluid antigens (HCF Ag)' used in diagnosis of hydatid disease, antigen 5 has been shown to contain epitope(s) with high specificity to E. granulosus (2) . Hydatidosis is associated with immediate-type hypersensitivity (3, 4) and patients with living E. granulosus cysts were found to have a higher concentration of IgE antibodies to HCF Ag. Among these, antigen 5 is the major one combining with reaginic antibodies (5) . Also, the evaluation of specific IgE in hydatidosis is considered as useful addition to the classical serodiagnosic tests (5, 6) .
Despite important progress made in the improvement of sensitivity of various diagnostic methods, the variability of the source of HCF Ag as well as the fact that HCF can contain host serum components remain the two major problems ofeffective diagnosis. This stresses the need for a standardized antigen such as a defined E. granulosus gene product. We have previously described (7) the specificity of protein epitope(s) of E. granulosus antigen 5 defined by a mouse monoclonal antibody (MAb; EG 02 154/12) and recognized by human hydatid sera. Recently, we reported the molecular cloning of an E. granulosus protein expressing a specific epitope of antigen 5 (8) 
XgtJJ expression library
Using a modified method ofChirgwin et al. (9) , total RNA was isolated from E. granulosus protoscoleces as previously described (8) . Doublestranded cDNA was synthesized from 300 Mg of total RNA (10) and cloned into the EcoRI site of the Xgtl 1 vector (8) . The expression library was screened with EG 02 154/12 MAb. After incubation with horseradish peroxidase-conjugated anti-mouse IgG (Diagnostic Pasteur, Marnes-la-Coquette, France), staining was performed with 4-chloro-l-naphtol reagent.
Nucleotide sequencing cDNA inserts were subcloned in the M 13 mp 18 vector and both DNA strands were sequenced by the dideoxy chain termination reaction of Sanger et al. (11) using dye-labeled primers (12). Fluorescence of DNA fragments was detected by a model 370A DNA sequencer (Applied Biosystems, Inc., Foster City, CA). The amino acid comparison was made by using Swissprot (Geneva, Switzerland) and National Biomedical Research Foundation (Washington, DC) protein sequence database.
Western blotting Y1089 lysogenic bacteria were selected on the basis of their temperature sensitivity and bacterial extracts were analyzed in SDS-PAGE under reducing conditions (13) . Western blotting was performed according to Towbin et al. (14) .
Peptide synthesis
Peptides were synthesized by a stepwise solid-phase method (15) ), Ser (OBzl). Amino acids were introduced using symmetric anhydride activation in dimethylformamide (DMF) (single coupling), except for Gln, which was introduced using the dicyclohexylcarboiimide/hydroxybenzotriazole activation protocol. At the end of the synthesis, the amino-terminal protecting Boc group was removed, and the peptide was acetylated using acetic anhydride. Final deprotection and cleavage of the peptidyl resins was by high hydrogen fluoride (HF) procedure, for 1 h at 0°C. The cleaved deprotected peptide was precipitated with cold diethylether and then dissolved in 5% acetic acid and lyophilized. Crude peptide was purified by gel filtration (TSK HW40S, Merck, Darmstadt, FRG) followed by reversed-phase HPLC on a 5 Am, 300A Nucleosil C18 (Macherey Nagel, Duren, FRG) column (0.5 in X 500 mm), using a very resolutive 3-h gradient from buffer Al (0.05% TFA in water) to 60% buffer Bi (0.05% TFA/75% acetonitrile/25% water), flow rate 2 ml/mn. The hydrochloride form of the peptide was obtained using a step gradient procedure from buffer A2 (pH 3 HCO in water) to buffer B2 (pH 3 HCO 50%/isopropanol 50%), on a 5 Mm, 300A Nucleosil C18 column (0.5 in X 75 mm), flow rate 2 ml/mn. Peptide was checked for homogeneity by analytical reversedphase HPLC on a 5jum Vydac C18 column (1/4 in X 250 mm), flow rate 0.7 ml/mn. The peptide was eluted as a single sharp peak. Detection was by absorbance at 215 nm.
Analytical methods
Hydrolysis of the peptide and amino acid analysis. Hydrolysis of the peptide was performed with 6N HCl/phenol (10:1) at 1 10°C for 24 h in evacuated sealed tube. Amino acids were quantified on an amino acid analyzer (model 7 
Results
Selection and sequence analysis ofcDNA clones recognized by the MAb EG 02 154/12. The specific MAb to antigen 5 was used to screen the cDNA library constructed from E. granulosus protoscoleces RNA. In addition to the Eg6 clone previously characterized (8), a second clone designated Egl4 was selected and further studied. The Egl4 clone contained a DNA insert of 137 bp and exhibited one open reading frame, in phase with the Xgt 11, encoding for 37 amino acids. Both sequences were represented using the hydrophobic cluster analysis plot described by Lemesle-Varloot et al. (16) (Fig. 1, B and C) . This method, together with more conventional methods for the prediction of secondary structure, suggest an organization in the form of helical stretches. The longitudinal distribution of the hydrophobic cluster along the helical plot is strongly evocative of an a-helical coiled-coil structure, such as the well known rabbit myosin heavy chain of skeletal muscle (Fig. I A) .
Beside these common structural properties, the Egl4 and Eg6 clones showed limited sequence homologies (Fig. 2) . However, on the graphic representation, these discontinuous sequence homologies formed two topographical patterns, present on both fragments, that could explain the cross-reactivity observed with the EG 02 154/12 MAb. In addition, the high proportion ofcharged or polar residues in these homologous structures could account for their presence in predominantly exposed areas on the native antigen.
Selection of a synthetic peptide antigen. Helical organization can be conveniently mimicked by long peptides (17 (Fig. 2) and encompassing both homologous patches (Fig. 1 B) . In order to introduce stabilizing charge interactions between extremities of this peptide designated 89-122 and the helix dipole (18), the amino-terminal end was a negatively charged glutamic residue while the carboxyl-terminal end was a positively charged lysine residue.
Helicity ofpeptide 89-122. The helical organization of the peptide was assessed by circular dichroism studies, performed at room temperature, in aqueous or aqueous-trifluoroethanol solution. Results presented in Fig. 3 showed that both spectra were characteristic of a significant helical organization, with minima occurring at 202-207 and 222-223 nm, and a positive value near 190 nm. Taking 0222 = -35,700 deg cm2/dmol for 100% helicity, we calculated a 14% helix content in aqueous medium, and a 74% helix content in aqueous-trifluoroethanol medium.
Binding inhibition ofEG 02 154/12 MAb and human hydatid sera to FP6 or to HCFAg by a synthetic peptide. The peptide 89-122 was used in ELISA inhibition experiments to assess its capacity to inhibit binding of the MAb and human hydatid sera to FP6 or to HCF Ag. As shown in Fig. 4 A, strong inhibitions of binding of the MAb (80%) and human hydatid sera (60%) to FP6 were obtained with the peptide 89-122. This structure was also able to significantly inhibit the binding of these antibodies to HCF Ag (65% and 45% respectively) (Fig. 4  B) . The binding inhibition was more effective for the MAb than for human hydatid sera. No significant inhibition was observed with an unrelated helix-forming (41 amino acids) synthetic peptide (19) corresponding to the P. falciparum liver stage antigen (LSA) (20) .
These results suggested that the peptide 89-122 was able to mimic binding site(s) recognized specifically by the MAb and human hydatid sera. Further study of human sera reactivity to this peptide was thus undertaken.
Human antibody response to the synthetic peptide 89-122. The reactivity ofsera from patients infected with E. granulosus or other parasites to the peptide 89-122 used as a solid phase antigen was evaluated by ELISA experiments. Using different dilutions of sera, results in Fig. 5 show that a significant antibody binding occurred only with anti-E. granulosus sera. Binding levels ofanti-E. multilocularis, anti-T. saginata, and anti-S. mansoni sera were lower as were that of normal human sera. Tested against an unrelated synthetic peptide (LSA), all these sera gave a similar low level of background (not shown). ELISA experiments were also performed to assess the immunodiagnostic value of the peptide 89-122. Two types of human antibody response (IgG-A-M and IgE) were analyzed. Using the upper limit ofpositive values as three standard deviations above the mean ofthe control group, a high binding sensitivity (85%) and a good specificity (86%) were observed in IgG-A-M response analysis (Fig. 6 ). When we compared these results to that obtained with FP6 in Western blotting (Table I) , we could observe an improvement of the specificity indicating the particular interest of the peptide 89-122 for diagnosis of hydatid disease.
More interestingly, IgE response to the peptide 89-122 showed a high specificity (100%) for E. granulosus-infected patients (Table I) . No IgE reactivity could be detected with 52 sera from other parasitic diseases whereas 60% ofhuman hyda- tid sera (24/40) were positive in this IgE ELISA. Using an unrelated synthetic peptide (LSA) as a control, no significant reactivity was obtained in both ELISAs (not shown).
The sensitivity and specificity of this test were compared to IgE ELISA performed with whole HCF Ag (Fig. 7) . The reactivity of IgE to the peptide 89-122 seems to be more specific (100%) for E. granulosus while 32% (6/19) of cestode-infected sera cross-reacted with HCF Ag. IgE antibodies from 29 
Discussion
Immunodiagnosis of hydatidosis has been based, during the last two decades, on the detection of circulating antibodies to antigen 5, the major immunogen of E. granulosus (2, 21, 22) . With the development of new tests with increased sensitivity, there remains the possibility offalse-positive reactions assigned mainly to host serum components that could pass through cyst membranes (23) (24) (25) . Molecular characterization ofE. granulosus antigens could contribute to the resolution of such prob-
We have previously demonstrated a particular immunogenicity and specificity ofa protein epitope on the native antigen 5 (7). Binding of human antibodies from patients with hydatid disease to this epitope is specifically inhibited by EG 02 154/12 MAb raised against the antigen 5. With the aim ofproducing a recombinant antigen for diagnosis of hydatid disease, we have isolated and characterized an E. granulosus recombinant protein expressing an immunogenic epitope target of human hydatid sera and EG 02 154/12 MAb (8) .
Further screening of the cDNA library with the MAb allowed the isolation of a second clone (Egl4). The latter has no homology with the two known cloned E. granulosus antigens that may be involved in protecting the parasite from the host immune system (26, 27) . Also, no significant homology can be observed with other published sequences. However, when compared to Eg6, Egl4 clone showed a limited amino acid sequence homology.
Recent work regarding assessment of secondary and tertiary structure ofproteins from their amino acid sequence have proved that hydrophobic cluster analysis is a very efficient method of analyzing and comparing protein sequences (28) . This method has been applied to obtain structural and func- tional information for a large number of proteins (16) The isotypic profile of human antibody response to HCF Ag has been shown to have an interesting prognostic role in hydatidosis (29) (30) (31) . According to Dessaint et al. (5) , a higher concentration of specific IgE antibodies is detected in patients with living E. granulosus cysts. The IgE level seems to decrease with the loss of viability of the cysts after treatment of hepatic hydatid disease with mebendazole (32) . In view of this important IgE response, the immediate-type hypersensitivity test, also known as the Casoni test (33) , has contributed to the immunodiagnosis of hydatidosis (3, 4, 34) , although, the use of whole HCF Ag leads to false-positive reactions with other helminthiasis (35, 36) . Among E. granulosus antigens identified as allergens (37) (38) (39) , antigen 5 is a major antigen reacting with reaginic antibodies (5) . Using the peptide 89-122 as a solidphase antigen in ELISA, we could demonstrate that IgE antibodies from 60% of hydatid patient sera bound specifically to this peptide. Such sensitivity remained important in comparison with that obtained with HCF Ag (72%). These data suggest that the peptide 89-122 may represent one major hydatid allergen binding-site recognized by reaginic antibodies from hydatid patient sera.
The use ofthis peptide as a standardized antigen in immediate-type hypersensitivity test should be of value for the diagnosis of hydatidosis both in humans and animals. Such a test may prove a useful adjunct to detection of specific antibody against this defined peptide in serodiagnosis and treatment surveillance.
